Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA.
Am J Transplant. 2015 May;15(5):1173-9. doi: 10.1111/ajt.13233. Epub 2015 Mar 31.
The American Society of Transplantation (AST) and American Society of Transplant Surgeons (ASTS) convened a workshop on June 2-3, 2014, to explore increasing both living and deceased organ donation in the United States. Recent articles in the lay press on illegal organ sales and transplant tourism highlight the impact of the current black market in kidneys that accompanies the growing global organ shortage. We believe it important not to conflate the illegal market for organs, which we reject in the strongest possible terms, with the potential in the United States for concerted action to remove all remaining financial disincentives for donors and critically consider testing the impact and acceptability of incentives to increase organ availability in the United States. However, we do not support any trials of direct payments or valuable considerations to donors or families based on a process of market-assigned values of organs. This White Paper represents a summary by the authors of the deliberations of the Incentives Workshop Group and has been approved by both AST and ASTS Boards.
美国移植学会（AST）和美国移植外科医师学会（ASTS）于 2014 年 6 月 2 日至 3 日召开了一次研讨会，旨在探讨如何增加美国的活体和已故器官捐赠。最近，通俗媒体上有关非法器官销售和移植旅游的文章强调了当前伴随全球器官短缺日益严重的肾脏黑市的影响。我们认为，重要的是不要将我们强烈反对的器官非法市场与美国采取协调行动消除所有剩余的器官捐赠经济障碍的可能性混为一谈，并认真考虑测试在美国增加器官供应的激励措施的影响和可接受性。然而，我们不支持任何基于器官市场定价过程向捐赠者或其家属提供直接付款或有价值考虑的试验。本白皮书代表激励措施研讨会小组作者的讨论总结，并已获得 AST 和 ASTS 董事会的批准。
